John B. Thomas
Corporate Officer/Principal chez NIRI NY Chapter
Postes actifs de John B. Thomas
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| NIRI NY Chapter | Corporate Officer/Principal | - | - |
Historique de carrière de John B. Thomas
Anciens postes connus de John B. Thomas
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Investor Relations Contact | 01/05/2015 | 01/01/2017 |
| ABBOTT LABORATORIES | Investor Relations Contact | 01/12/1995 | 01/05/2013 |
| Public Communications Contact | 01/12/1995 | 01/05/2013 | |
| Abbott Fund | President | - | - |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Investor Relations Contact | 17/04/2018 | - |
| Public Communications Contact | 17/04/2018 | - | |
| University of Mississippi | Corporate Officer/Principal | - | - |
Formation de John B. Thomas
| University of Mississippi | Undergraduate Degree |
| Lake Forest Graduate School of Management | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 7 |
| Irlande | 2 |
Opérationnelle
| Investor Relations Contact | 3 |
| Public Communications Contact | 2 |
| Corporate Officer/Principal | 2 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| Entreprise privées | 4 |
|---|---|
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
| Abbott Fund | |
| NIRI NY Chapter |
- Bourse
- Insiders
- John B. Thomas
- Expérience